These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37703640)

  • 1. Cross-talk between B cells, microglia and macrophages, and implications to central nervous system compartmentalized inflammation and progressive multiple sclerosis.
    Touil H; Li R; Zuroff L; Moore CS; Healy L; Cignarella F; Piccio L; Ludwin S; Prat A; Gommerman J; Bennett FC; Jacobs D; Benjamins JA; Lisak RP; Antel JP; Bar-Or A
    EBioMedicine; 2023 Oct; 96():104789. PubMed ID: 37703640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human central nervous system astrocytes support survival and activation of B cells: implications for MS pathogenesis.
    Touil H; Kobert A; Lebeurrier N; Rieger A; Saikali P; Lambert C; Fawaz L; Moore CS; Prat A; Gommerman J; Antel JP; Itoyama Y; Nakashima I; Bar-Or A;
    J Neuroinflammation; 2018 Apr; 15(1):114. PubMed ID: 29673365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuronal injury in chronic CNS inflammation.
    Zindler E; Zipp F
    Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Ependymal-in" Gradient of Thalamic Damage in Progressive Multiple Sclerosis.
    Magliozzi R; Fadda G; Brown RA; Bar-Or A; Howell OW; Hametner S; Marastoni D; Poli A; Nicholas R; Calabrese M; Monaco S; Reynolds R
    Ann Neurol; 2022 Oct; 92(4):670-685. PubMed ID: 35748636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Connecting Immune Cell Infiltration to the Multitasking Microglia Response and TNF Receptor 2 Induction in the Multiple Sclerosis Brain.
    Veroni C; Serafini B; Rosicarelli B; Fagnani C; Aloisi F; Agresti C
    Front Cell Neurosci; 2020; 14():190. PubMed ID: 32733206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microglia are activated to become competent antigen presenting and effector cells in the inflammatory environment of the Theiler's virus model of multiple sclerosis.
    Mack CL; Vanderlugt-Castaneda CL; Neville KL; Miller SD
    J Neuroimmunol; 2003 Nov; 144(1-2):68-79. PubMed ID: 14597100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meningeal inflammation and cortical demyelination in acute multiple sclerosis.
    Bevan RJ; Evans R; Griffiths L; Watkins LM; Rees MI; Magliozzi R; Allen I; McDonnell G; Kee R; Naughton M; Fitzgerald DC; Reynolds R; Neal JW; Howell OW
    Ann Neurol; 2018 Dec; 84(6):829-842. PubMed ID: 30362156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bruton's tyrosine kinase as a promising therapeutic target for multiple sclerosis.
    Saberi D; Geladaris A; Dybowski S; Weber MS
    Expert Opin Ther Targets; 2023; 27(4-5):347-359. PubMed ID: 37272515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulocyte-macrophage colony-stimulating factor-stimulated human macrophages demonstrate enhanced functions contributing to T-cell activation.
    Farzam-Kia N; Lemaître F; Carmena Moratalla A; Carpentier Solorio Y; Da Cal S; Jamann H; Klement W; Antel J; Duquette P; Girard JM; Prat A; Larochelle C; Arbour N
    Immunol Cell Biol; 2023 Jan; 101(1):65-77. PubMed ID: 36260372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MerTK Is a Functional Regulator of Myelin Phagocytosis by Human Myeloid Cells.
    Healy LM; Perron G; Won SY; Michell-Robinson MA; Rezk A; Ludwin SK; Moore CS; Hall JA; Bar-Or A; Antel JP
    J Immunol; 2016 Apr; 196(8):3375-84. PubMed ID: 26962228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-13 immune gene therapy prevents CNS inflammation and demyelination via alternative activation of microglia and macrophages.
    Guglielmetti C; Le Blon D; Santermans E; Salas-Perdomo A; Daans J; De Vocht N; Shah D; Hoornaert C; Praet J; Peerlings J; Kara F; Bigot C; Mai Z; Goossens H; Hens N; Hendrix S; Verhoye M; Planas AM; Berneman Z; van der Linden A; Ponsaerts P
    Glia; 2016 Dec; 64(12):2181-2200. PubMed ID: 27685637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibronectin aggregates promote features of a classically and alternatively activated phenotype in macrophages.
    Sikkema AH; Stoffels JMJ; Wang P; Basedow FJ; Bulsink R; Bajramovic JJ; Baron W
    J Neuroinflammation; 2018 Aug; 15(1):218. PubMed ID: 30071854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CSF1R signaling is a regulator of pathogenesis in progressive MS.
    Hagan N; Kane JL; Grover D; Woodworth L; Madore C; Saleh J; Sancho J; Liu J; Li Y; Proto J; Zelic M; Mahan A; Kothe M; Scholte AA; Fitzgerald M; Gisevius B; Haghikia A; Butovsky O; Ofengeim D
    Cell Death Dis; 2020 Oct; 11(10):904. PubMed ID: 33097690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Bruton´s tyrosine kinase in different type of brain lesions of multiple sclerosis patients and during experimental demyelination.
    Elkjaer ML; Waede MR; Kingo C; Damsbo K; Illes Z
    Front Immunol; 2023; 14():1264128. PubMed ID: 38022591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-9 regulates macrophage activation in the progressive multiple sclerosis brain.
    Donninelli G; Saraf-Sinik I; Mazziotti V; Capone A; Grasso MG; Battistini L; Reynolds R; Magliozzi R; Volpe E
    J Neuroinflammation; 2020 May; 17(1):149. PubMed ID: 32375811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microglial Phagocytosis-Rational but Challenging Therapeutic Target in Multiple Sclerosis.
    Pinto MV; Fernandes A
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced inflammation accompanies diminished myelin damage and repair in the NG2 null mouse spinal cord.
    Kucharova K; Chang Y; Boor A; Yong VW; Stallcup WB
    J Neuroinflammation; 2011 Nov; 8():158. PubMed ID: 22078261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential macrophage/microglia activation in neocortical EAE lesions in the marmoset monkey.
    Merkler D; Böscke R; Schmelting B; Czéh B; Fuchs E; Brück W; Stadelmann C
    Brain Pathol; 2006 Apr; 16(2):117-23. PubMed ID: 16768751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of 'homeostatic' microglia and patterns of their activation in active multiple sclerosis.
    Zrzavy T; Hametner S; Wimmer I; Butovsky O; Weiner HL; Lassmann H
    Brain; 2017 Jul; 140(7):1900-1913. PubMed ID: 28541408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bruton's Tyrosine Kinase Inhibition in the Treatment of Preclinical Models and Multiple Sclerosis.
    Steinmaurer A; Wimmer I; Berger T; Rommer PS; Sellner J
    Curr Pharm Des; 2022; 28(6):437-444. PubMed ID: 34218776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.